Three-Year CD4/CD8 Ratio Recovery After Initiation of Dual Versus Triple Integrase Inhibitor–Based Therapy in Naïve Adults With HIV

Clicks: 1
ID: 318064
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #192 of 208 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 208 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract From 21,233 adults in the Spanish HIV Research Network, we used propensity score-matching to compare CD4/CD8 ratio recovery between dolutegravir-based 2DR and second-generation integrase inhibitor-based 3DR. No detectable differences in CD4/CD8 normalization were observed at three years across all cutoffs, suggesting that immune recovery does not differ between strategies.
Reference Key
openalex_W7165448145 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Roser Navarro‐Soler, Alejandro García García, Juan Macı́as, Jorge Sanchez-Villegas, José Luis Blanco Arévalo, Dácil García Rosado, Antonio Ocampo Hermida, Cristina Gómez Ayerbe, Santiago Moreno, Javier Martínez‐Sanz, Sergio Serrano‐Villar
Journal Open forum infectious diseases
Year 2026
DOI
10.1093/ofid/ofag374
URL
https://doi.org/10.1093/ofid/ofag374
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.